Subclone-specific microenvironmental impact and drug response in refractory multiple myeloma revealed by single‐cell transcriptomics

Abstract Virtually all patients with multiple myeloma become unresponsive to treatment over time. Relapsed/refractory multiple myeloma (RRMM) is accompanied by the clonal evolution of myeloma cells with heterogeneous genomic aberrations and profound changes of the bone marrow microenvironment (BME)....

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Stephan M. Tirier, Jan-Philipp Mallm, Simon Steiger, Alexandra M. Poos, Mohamed H. S. Awwad, Nicola Giesen, Nicola Casiraghi, Hana Susak, Katharina Bauer, Anja Baumann, Lukas John, Anja Seckinger, Dirk Hose, Carsten Müller-Tidow, Hartmut Goldschmidt, Oliver Stegle, Michael Hundemer, Niels Weinhold, Marc S. Raab, Karsten Rippe
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Q
Acceso en línea:https://doaj.org/article/fa70b923d8a843a39ddf7f12f81781e7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:fa70b923d8a843a39ddf7f12f81781e7
record_format dspace
spelling oai:doaj.org-article:fa70b923d8a843a39ddf7f12f81781e72021-12-05T12:21:44ZSubclone-specific microenvironmental impact and drug response in refractory multiple myeloma revealed by single‐cell transcriptomics10.1038/s41467-021-26951-z2041-1723https://doaj.org/article/fa70b923d8a843a39ddf7f12f81781e72021-11-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-26951-zhttps://doaj.org/toc/2041-1723Abstract Virtually all patients with multiple myeloma become unresponsive to treatment over time. Relapsed/refractory multiple myeloma (RRMM) is accompanied by the clonal evolution of myeloma cells with heterogeneous genomic aberrations and profound changes of the bone marrow microenvironment (BME). However, the molecular mechanisms that drive drug resistance remain elusive. Here, we analyze the heterogeneous tumor cell population and its complex interaction network with the BME of 20 RRMM patients by single cell RNA-sequencing before/after treatment. Subclones with chromosome 1q-gain express a specific transcriptomic signature and frequently expand during treatment. Furthermore, RRMM cells shape an immune suppressive BME by upregulation of inflammatory cytokines and close interaction with the myeloid compartment. It is characterized by the accumulation of PD1+ γδ T-cells and tumor-associated macrophages as well as the depletion of hematopoietic progenitors. Thus, our study resolves transcriptional features of subclones in RRMM and mechanisms of microenvironmental reprogramming with implications for clinical decision-making.Stephan M. TirierJan-Philipp MallmSimon SteigerAlexandra M. PoosMohamed H. S. AwwadNicola GiesenNicola CasiraghiHana SusakKatharina BauerAnja BaumannLukas JohnAnja SeckingerDirk HoseCarsten Müller-TidowHartmut GoldschmidtOliver StegleMichael HundemerNiels WeinholdMarc S. RaabKarsten RippeNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-16 (2021)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Stephan M. Tirier
Jan-Philipp Mallm
Simon Steiger
Alexandra M. Poos
Mohamed H. S. Awwad
Nicola Giesen
Nicola Casiraghi
Hana Susak
Katharina Bauer
Anja Baumann
Lukas John
Anja Seckinger
Dirk Hose
Carsten Müller-Tidow
Hartmut Goldschmidt
Oliver Stegle
Michael Hundemer
Niels Weinhold
Marc S. Raab
Karsten Rippe
Subclone-specific microenvironmental impact and drug response in refractory multiple myeloma revealed by single‐cell transcriptomics
description Abstract Virtually all patients with multiple myeloma become unresponsive to treatment over time. Relapsed/refractory multiple myeloma (RRMM) is accompanied by the clonal evolution of myeloma cells with heterogeneous genomic aberrations and profound changes of the bone marrow microenvironment (BME). However, the molecular mechanisms that drive drug resistance remain elusive. Here, we analyze the heterogeneous tumor cell population and its complex interaction network with the BME of 20 RRMM patients by single cell RNA-sequencing before/after treatment. Subclones with chromosome 1q-gain express a specific transcriptomic signature and frequently expand during treatment. Furthermore, RRMM cells shape an immune suppressive BME by upregulation of inflammatory cytokines and close interaction with the myeloid compartment. It is characterized by the accumulation of PD1+ γδ T-cells and tumor-associated macrophages as well as the depletion of hematopoietic progenitors. Thus, our study resolves transcriptional features of subclones in RRMM and mechanisms of microenvironmental reprogramming with implications for clinical decision-making.
format article
author Stephan M. Tirier
Jan-Philipp Mallm
Simon Steiger
Alexandra M. Poos
Mohamed H. S. Awwad
Nicola Giesen
Nicola Casiraghi
Hana Susak
Katharina Bauer
Anja Baumann
Lukas John
Anja Seckinger
Dirk Hose
Carsten Müller-Tidow
Hartmut Goldschmidt
Oliver Stegle
Michael Hundemer
Niels Weinhold
Marc S. Raab
Karsten Rippe
author_facet Stephan M. Tirier
Jan-Philipp Mallm
Simon Steiger
Alexandra M. Poos
Mohamed H. S. Awwad
Nicola Giesen
Nicola Casiraghi
Hana Susak
Katharina Bauer
Anja Baumann
Lukas John
Anja Seckinger
Dirk Hose
Carsten Müller-Tidow
Hartmut Goldschmidt
Oliver Stegle
Michael Hundemer
Niels Weinhold
Marc S. Raab
Karsten Rippe
author_sort Stephan M. Tirier
title Subclone-specific microenvironmental impact and drug response in refractory multiple myeloma revealed by single‐cell transcriptomics
title_short Subclone-specific microenvironmental impact and drug response in refractory multiple myeloma revealed by single‐cell transcriptomics
title_full Subclone-specific microenvironmental impact and drug response in refractory multiple myeloma revealed by single‐cell transcriptomics
title_fullStr Subclone-specific microenvironmental impact and drug response in refractory multiple myeloma revealed by single‐cell transcriptomics
title_full_unstemmed Subclone-specific microenvironmental impact and drug response in refractory multiple myeloma revealed by single‐cell transcriptomics
title_sort subclone-specific microenvironmental impact and drug response in refractory multiple myeloma revealed by single‐cell transcriptomics
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/fa70b923d8a843a39ddf7f12f81781e7
work_keys_str_mv AT stephanmtirier subclonespecificmicroenvironmentalimpactanddrugresponseinrefractorymultiplemyelomarevealedbysinglecelltranscriptomics
AT janphilippmallm subclonespecificmicroenvironmentalimpactanddrugresponseinrefractorymultiplemyelomarevealedbysinglecelltranscriptomics
AT simonsteiger subclonespecificmicroenvironmentalimpactanddrugresponseinrefractorymultiplemyelomarevealedbysinglecelltranscriptomics
AT alexandrampoos subclonespecificmicroenvironmentalimpactanddrugresponseinrefractorymultiplemyelomarevealedbysinglecelltranscriptomics
AT mohamedhsawwad subclonespecificmicroenvironmentalimpactanddrugresponseinrefractorymultiplemyelomarevealedbysinglecelltranscriptomics
AT nicolagiesen subclonespecificmicroenvironmentalimpactanddrugresponseinrefractorymultiplemyelomarevealedbysinglecelltranscriptomics
AT nicolacasiraghi subclonespecificmicroenvironmentalimpactanddrugresponseinrefractorymultiplemyelomarevealedbysinglecelltranscriptomics
AT hanasusak subclonespecificmicroenvironmentalimpactanddrugresponseinrefractorymultiplemyelomarevealedbysinglecelltranscriptomics
AT katharinabauer subclonespecificmicroenvironmentalimpactanddrugresponseinrefractorymultiplemyelomarevealedbysinglecelltranscriptomics
AT anjabaumann subclonespecificmicroenvironmentalimpactanddrugresponseinrefractorymultiplemyelomarevealedbysinglecelltranscriptomics
AT lukasjohn subclonespecificmicroenvironmentalimpactanddrugresponseinrefractorymultiplemyelomarevealedbysinglecelltranscriptomics
AT anjaseckinger subclonespecificmicroenvironmentalimpactanddrugresponseinrefractorymultiplemyelomarevealedbysinglecelltranscriptomics
AT dirkhose subclonespecificmicroenvironmentalimpactanddrugresponseinrefractorymultiplemyelomarevealedbysinglecelltranscriptomics
AT carstenmullertidow subclonespecificmicroenvironmentalimpactanddrugresponseinrefractorymultiplemyelomarevealedbysinglecelltranscriptomics
AT hartmutgoldschmidt subclonespecificmicroenvironmentalimpactanddrugresponseinrefractorymultiplemyelomarevealedbysinglecelltranscriptomics
AT oliverstegle subclonespecificmicroenvironmentalimpactanddrugresponseinrefractorymultiplemyelomarevealedbysinglecelltranscriptomics
AT michaelhundemer subclonespecificmicroenvironmentalimpactanddrugresponseinrefractorymultiplemyelomarevealedbysinglecelltranscriptomics
AT nielsweinhold subclonespecificmicroenvironmentalimpactanddrugresponseinrefractorymultiplemyelomarevealedbysinglecelltranscriptomics
AT marcsraab subclonespecificmicroenvironmentalimpactanddrugresponseinrefractorymultiplemyelomarevealedbysinglecelltranscriptomics
AT karstenrippe subclonespecificmicroenvironmentalimpactanddrugresponseinrefractorymultiplemyelomarevealedbysinglecelltranscriptomics
_version_ 1718372053373943808